Post-earnings recap
Reported
Tue, Oct 29, 2013
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Charles River Laboratories reported an EPS of $0.79, exceeding expectations by 12.7%. However, the stock fell slightly by 0.26% following the earnings report. The lack of revenue data and management commentary may have contributed to the stock's decline.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.79 | N/A | +12.70% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.